Prediction of nonsmall cell lung cancer sensitivity to cisplastin and paclitaxel based on marker gene expression

Author： Boyarskikh U. Kondrakhin Yu. Yevshin I. Sharipov R. Komelkov A. Musatkina E. Tchevkina E. Sukoyan M. Kolpakov F. Kashkin K. Filipenko M.

Publisher： MAIK Nauka/Interperiodica

ISSN： 0026-8933

Source： Molecular Biology, Vol.45, Iss.4, 2011-08, pp. : 600-607

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer

By Xu Chunhua Hao Keke Yu Like Zhang Xiuwei

Biomarkers, Vol. 19, Iss. 4, 2014-06 ,pp. : 287-290

Informa Healthcare

Access to resources Recommend Favorite

The development of immunotherapies for non-small cell lung cancer

By Salgaller Michael L

Expert Opinion on Biological Therapy, Vol. 2, Iss. 3, 2002-03 ,pp. : 265-278

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab in non-small cell lung cancer

By Ademuyiwa Foluso O Hanna Nasser

Expert Opinion on Biological Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 107-113

Informa Healthcare

Access to resources Recommend Favorite

Arf6, RalA, and BIRC5 protein expression in nonsmall cell lung cancer

By Knizhnik A. Kovaleva O. Laktionov K. Mochalnikova V. Komelkov A. Tchevkina E. Zborovskaya I.

Molecular Biology, Vol. 45, Iss. 2, 2011-04 ,pp. : 275-282

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Shedding of c-Met ectodomain correlates with c-Met expression in non-small cell lung cancer

By Fu Le

Biomarkers, Vol. 18, Iss. 2, 2013-03 ,pp. : 126-135

Informa Healthcare

Access to resources Recommend Favorite